Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
MAO BAO INC.	1732	Taiwan S.E.	272,208	28.75 TWD	Stock
BAO VIET HOLDINGS	BVH	Ho Chi Minh S.E.	285,820	40,550 VND	Stock
BAO VIET SECURITIES	BVS	HANOI S.E.	896,911	40,100 VND	Stock
BAO MINH INSURANCE CORPORATION	BMI	Ho Chi Minh S.E.	83,153	23,500 VND	Stock
BAO SHEN HOLDINGS LIMITED	8151	Hong Kong S.E.	0	0.063 HKD	Stock
BAO NGOC INVESTMENT PRODUCTION CORPORATION	BNA	HANOI S.E.	117,150	10,600 VND	Stock
TON YI INDUSTRIAL CORP.	9907	Taiwan S.E.	1,673,627	15.1 TWD	Stock
SHENG YI DEVELOPMENT CO.,LTD	5455	Taipei Exchange	55,025	57.3 TWD	Stock
TU YI HOLDING COMPANY LIMITED	1701	Hong Kong S.E.	150,769	0.158 HKD	Stock
QING SONG HEALTH CO.,LTD.	6931	Taipei Exchange	22,296	103 TWD	Stock

See all

News (18)

AXT : Reply to Audit Inquiry Letter onApplication for Initial Public Offering and STAR Market Listing of Shares by Beijing Tongmei Xtal Technology Co., Ltd - Form 8-K	18/04/22	PU
Pingtan Marine : Amendment to Annual Report (Form 10-K/A)	19/10/21	PU
Weihai City Commercial Bank : NOTICE OF 2020 ANNUAL GENERAL MEETING	12/05/21	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : (1) PROPOSED ADOPTION OF THE 2021 RESTRICTED INCENTIVE SCHEME (2) CONNECTED TRANSACTION - PROPOSED ISSUE AND GRANT OF NEW A SHARES UNDER THE INCENTIVE SCHEME PURSUANT TO SPECIFIC MANDATE	06/04/21	PU
Guangzhou Baiyunshan Pharmaceutical : SUMMARY OF THE 2020 ANNUAL REPORT	18/03/21	PU
Fresenius : Participations in affiliated and associated companies (PDF, 0.85 MB)	18/03/21	PU
China International Marine Containers : DISCLOSEABLE AND CONNECTED TRANSACTION	16/09/20	PU
Shanghai Fudan Zhangjiang Bio Pharmaceutical : Interim Report For the Six Months Ended 30 June 2020	10/09/20	PU
Shanghai Fosun Pharmaceutical : Interim Report 2020	10/09/20	PU
WuXi AppTec : (1) PROPOSED ADOPTION OF THE LIST OF INCENTIVE PARTICIPANTS; AND (2) NOTICE OF THE THIRD H SHARE CLASS MEETING FOR 2019	04/10/19	PU
Zhengzhou Coal Mining Machinery : PROPOSED ADOPTION OF THE 2019 A SHARE OPTION INCENTIVE SCHEME; PROPOSED AMENDMENT TO THE ARTICLES OF ASSOCIATION IN RELATION TO THE COMPOSITION OF THE BOARD OF DIRECTORS; PROPOSED ELECTION OF A NEW INDEPENDENT NON-EXECUTIVE DIRECTOR; AND NOTICE OF THE SECOND EXTRAORDINARY GENERAL MEETING OF 2019; NOTICE OF THE FIRST H SHAREHOLDERS CLASS MEETING OF 2019	20/09/19	PU
Chi-Med Reports 2019 Interim Results and Provides Updates on Key Clinical Programs	30/07/19	GL
235 Earn Regulatory Affairs Certification (RAC)	08/02/19	GL
Sheen Tai Holdings Group Company Limited cancelled the acquisition of Shenzhen Yi Er Shan Photovoltaic Electricity Company Limited from Li Xiu Yun.	22/06/16	CI
Sheen Tai Holdings Group Company Limited entered into the sale and purchase agreement to acquire Shenzhen Yi Er Shan Photovoltaic Electricity Company Limited from Li Xiu Yun for HKD 90 million.	11/10/15	CI
Bao Shuping, Chief Executive Officer and President of Shanghai Hyron Software Co., Ltd. completed the acquisition of an additional 20.59% stake in Shanghai Hyron Software Co., Ltd. from Shanghai JTU Information Investment Co., Ltd., Omron Co.,Ltd. and other shareholders.	07/05/14	CI
Bao Shuping, Chief Executive Officer and President of Shanghai Hyron Software Co., Ltd. made a tender offer to acquire an additional 43.16% stake in Shanghai Hyron Software Co., Ltd. from Shanghai JTU Information Investment Co., Ltd., Omron Co.,Ltd. and other shareholders for approximately CNY 740 million.	20/12/13	CI
Hopson Development Holdings Limited : CHANGE OF EXECUTIVE DIRECTOR, DEPUTY CHAIRMAN AND CHIEF FINANCIAL OFFICER (in PDF)	10/07/13	PU

Companies (30)

TIANSHENG PHARMACEUTICAL GROUP CO., LTD. 186 M $

Tiansheng Pharmaceutical Group Co LTD is a China-based company principally engaged in the research and development, manufacture and sales of pharmaceuticals. The Company's main products include pediatric lung cough particles, erythromycin enteric-coated c ...

TEAMWAY INTERNATIONAL GROUP HOLDINGS LIMITED 3 M $

Teamway International Group Holdings Limited, formerly Jin Bao Bao Holdings Limited, is an investment holding company principally engaged in the design, manufacture and sale of packaging products and structural components. Its packaging products are made ...

YI CHUN GREEN TECHNOLOGY CO., LTD. 41 M $

Yi Chun Green Technology Co Ltd is a Taiwan-based company mainly engaged in the recycle of diapers and the sale of recycled raw materials. Fibers, superabsorbent molecules and plastics decomposed from discarded diapers can be supplied to various paper pro ...

ZHEJIANG CHENG YI PHARMACEUTICAL CO., LTD. 373 M $

Zhejiang Cheng Yi Pharmaceutical Co., Ltd is a China-based company principally engaged in the research, development, production and sales of bulk pharmaceutical chemicals of chemical medicine and preparations. The Companyâs products are on the spectrum ...

BAO VIET SECURITIES 114 M $

Bao Viet Securities Company is a Vietnam-based provider of investment services. The Company offers securities brokerage services, underwriting services, custody services and investment advice to investors. It is also engaged in the trading of securities a ...

MAO BAO INC. 38 M $

Mao Bao Incorporated is a Taiwan-based company mainly engaged in the processing, manufacturing, sales and import and export trading of cleaning products. The Company's main products include laundry detergents, such as laundry concentrates, collar detergen ...

XINJIANG BA YI IRON & STEEL CO.,LTD. 639 M $

Xinjiang Ba Yi Iron & Steel Co., Ltd. is a China-based company principally engaged in the smelting, rolling, processing and sales of iron and steels, as well as the production and distribution of pressing steel products. The Company's products include def ...

MICROBIO CO., LTD. 725 M $

Microbio Co., Ltd. is a Taiwan-based company primarily engaged in the research, development, manufacture, distribution and wholesales of healthcare food products and pharmaceuticals. The Company provides fermentation products, including Tien Chun Bao (TCB ...

CHIA YI STEEL CO., LTD. 17 M $

CHIA YI STEEL CO., LTD. is principally engaged in the forging, processing and distribution of casting iron products. The Company primarily involves in the manufacture and precision processing of iron products, which are applied in mechanical parts, electr ...

JINFA LABI MATERNITY & BABY ARTICLES CO., LTD 315 M $

JINFA LABI MATERNITY & BABY ARTICLES CO., LTD. is a China-based company engaged in the research and development, manufacture and sales of infants' consumer goods. The Company has three own brands, Labi Baby, Xia Yi Dai and Bei Bi La Bi. Its products inclu ...

123Next

Insiders

Yi Qing Bao

Currently, Yi Qing Bao holds the position of Chairman-Supervisory Board at East Money Information Co., Ltd.

Qing Bao

Qing Bao is currently working as an Investment Manager at HuaAn Future Asset Management (Shanghai) Co., Ltd.
Previously, Bao worked as a Portfolio Manager at HuaAn Fund Management Co., Ltd.

Yi Bao

Yi Bao was the founder of Morgan Stanley Securities (China) Co., Ltd.
(founded in 2013) and Cedarlake Acquisition Corp.
(founded in 2021) where he held the titles of Chief Executive Officer and Chairman & Chief Executive Officer respectively.
Currently, Mr. Bao holds the position of Chairman at Granday Financial Leasing Co. Ltd.
and Director at Cedarlake Sponsor Ltd., Cedarlake Hk Advisors Ltd., Brocade River Merchants Group Ltd., Brocade River Merchants Hong Kong Ltd., Brocade River Merchants Ltd., Brocade River Merchants Capital Ltd., and Brocade River Merchants International Ltd.
Additionally, he is an Independent Non-Executive Director at Sino ICT Holdings Ltd.
since 2016.
Mr. Bao's former position was as a Managing Director at Morgan Stanley Asia Ltd.
Mr. Bao holds an MBA from The Wharton School of the University of Pennsylvania.

Qing Qing Yi

Qing Qing Yi is currently serving as the Vice Chairman at Hisun Pfizer Pharmaceuticals Co., Ltd.
since 2017.
Additionally, Mr. Yi holds the position of Independent Non-Executive Director at BeiGene Ltd.
since 2014, Non-Executive Director at JD Health International, Inc. since 2020, and Partner at Hillhouse Capital Group Ltd.
since 2005.
Previously, Mr. Yi served as the Chairman at Genor Biopharma Holdings Ltd.
from 2018 to 2021 and as a Non-Executive Director at Shanghai Junshi Biosciences Co., Ltd.
from 2016 to 2021.
Mr. Yi also held director positions at Gossamer Bio, Inc. and Hibercell, Inc. Mr. Yi obtained an MBA from the University of Southern California in 2003 and completed undergraduate studies at Shanghai Maritime University in 1995.

Qing Qing Yi

Qing Qing Yi currently works at Hillhouse Investment Management Ltd.
(Hong Kong), as Co-Chief Investment Officer from 2020 and HHLR Advisors Ltd., as Co-Chief Investment Officer.

No results for this search